BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6129147)

  • 1. Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice.
    Consroe P; Benedito MA; Leite JR; Carlini EA; Mechoulam R
    Eur J Pharmacol; 1982 Sep; 83(3-4):293-8. PubMed ID: 6129147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological investigation of convulsant gamma-aminobutyric acid (GABA) antagonists in amygdala-kindled rats.
    Kalichman MW
    Epilepsia; 1982 Apr; 23(2):163-71. PubMed ID: 7075571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
    Consroe P; Wolkin A
    J Pharmacol Exp Ther; 1977 Apr; 201(1):26-32. PubMed ID: 850145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endothelin-1 (ET-1) and endothelin-3 (ET-3) on convulsive seizures.
    Getova DP; Maslarova JE; Nikolov RK; Semkova IS
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):173-8. PubMed ID: 8046950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant profile of drugs which facilitate GABAergic transmission on convulsions mediated by a GABAergic mechanism.
    Rastogi SK; Ticku MK
    Neuropharmacology; 1986 Feb; 25(2):175-85. PubMed ID: 3010161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of neurotransmitter actions (GABA, glycine, and convulsants).
    Davidoff RA
    Res Publ Assoc Res Nerv Ment Dis; 1983; 61():53-85. PubMed ID: 6133327
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels.
    Vilela LR; Lima IV; Kunsch ÉB; Pinto HPP; de Miranda AS; Vieira ÉLM; de Oliveira ACP; Moraes MFD; Teixeira AL; Moreira FA
    Epilepsy Behav; 2017 Oct; 75():29-35. PubMed ID: 28821005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin.
    Pilip S; Urbańska EM; Swiader M; Włodarczyk D; Kleinrok Z; Czuczwar SJ; Turski WA
    Pol J Pharmacol; 2000; 52(4):267-73. PubMed ID: 11345482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDL 27,531 selectively reverses strychnine-induced seizures in mice.
    Kehne JH; Kane JM; Miller FP; Ketteler HJ; Braun DL; Senyah Y; Chaney SF; Abdallah A; Dudley MW; Ogden AM
    Br J Pharmacol; 1992 Aug; 106(4):910-6. PubMed ID: 1327393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.
    Swiader M; Gasior M; Wielosz M; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
    Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
    Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effects of some inhibitory neurotransmitter amino acids.
    Toth E; Lajtha A; Sarhan S; Seiler N
    Neurochem Res; 1983 Mar; 8(3):291-302. PubMed ID: 6134243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice.
    Shirazi-zand Z; Ahmad-Molaei L; Motamedi F; Naderi N
    Epilepsy Behav; 2013 Jul; 28(1):1-7. PubMed ID: 23644464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective susceptibility to inhibitors of GABA synthesis and antagonists of GABA(A) receptor in rats with genetic absence epilepsy.
    Vergnes M; Boehrer A; Reibel S; Simler S; Marescaux C
    Exp Neurol; 2000 Feb; 161(2):714-23. PubMed ID: 10686090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure susceptibility in DBA and C57 mice: the effects of various convulsants.
    Engstrom FL; Woodbury DM
    Epilepsia; 1988; 29(4):389-95. PubMed ID: 3292231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dihydroergotoxine on the susceptibility of rats to convulsions produced by different convulsant agents.
    Pericić D; Manev H
    Psychopharmacology (Berl); 1983; 80(2):171-3. PubMed ID: 6410446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of picolinic acid on seizure susceptibility in mice.
    Cioczek-Czuczwar A; Czuczwar P; Turski WA; Parada-Turska J
    Pharmacol Rep; 2017 Feb; 69(1):77-80. PubMed ID: 27907839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
    Klein BD; Jacobson CA; Metcalf CS; Smith MD; Wilcox KS; Hampson AJ; Kehne JH
    Neurochem Res; 2017 Jul; 42(7):1939-1948. PubMed ID: 28478594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
    Jones NA; Glyn SE; Akiyama S; Hill TD; Hill AJ; Weston SE; Burnett MD; Yamasaki Y; Stephens GJ; Whalley BJ; Williams CM
    Seizure; 2012 Jun; 21(5):344-52. PubMed ID: 22520455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs.
    Kosobud AE; Crabbe JC
    Brain Res; 1990 Aug; 526(1):8-16. PubMed ID: 2078820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.